Erythropoietin induces tumor regression and antitumor immune responses in murine myeloma models
Recombinant human erythropoietin (rHuEpo) has been used successfully in the treatment of cancer-related anemia. Clinical observations with several patients with multiple-myeloma treated with rHuEpo has shown, in addition to the improved quality of life, a longer survival than expected, considering t...
Guardat en:
| Publicat a: | Proc Natl Acad Sci U S A |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
National Academy of Sciences
2001
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC33184/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11309490/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.081275298 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|